Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.

Antimicrobial Agents and Chemotherapy
J Renneberg, M Walder

Abstract

The postantibiotic effects (PAEs) of imipenem and norfloxacin were tested against Staphylococcus aureus, Streptococcus (Enterococcus) faecalis, Escherichia coli, and Pseudomonas aeruginosa. Amikacin was tested against the same bacteria except Streptococcus faecalis. For in vitro tests, a viable count-washing method was used, and for in vivo tests, the thread technique in normal mice was used. All three drugs produced PAEs of 1.1 to 3.8 h in vitro and 1.4 to 4.3 h in vivo against the pathogens tested. In vitro and in vivo results correlated well. The PAE had a significantly (P less than 0.01 to 0.001) longer duration in vivo than in vitro, but the PAE of imipenem on Staphylococcus aureus was longer in vitro. The PAE was not due to residual antibiotics at the site of infection, and no PAE was obtained if at any time the antibiotic concentration at the infection site reached the MIC for the pathogen tested. The results indicate that the presence of a PAE may enable antibiotics to be given more intermittently without a loss of efficacy and that the PAE can only be induced if the level of the antibiotic exceeds the MIC for the pathogen in question for at least several minutes.

References

Oct 1, 1976·The Journal of Antibiotics·G P Bodey, T Pan
Feb 1, 1977·The Journal of Infectious Diseases·P J McDonaldC M Kunin
Jun 1, 1987·European Journal of Clinical Microbiology·K Fuursted
Feb 1, 1988·The Journal of Infectious Diseases·B VogelmanW A Craig
Jul 1, 1988·The Journal of Antimicrobial Chemotherapy·J Renneberg, M Walder
Jan 1, 1988·Scandinavian Journal of Infectious Diseases·I OdenholtO Cars
Dec 1, 1986·The Journal of Antimicrobial Chemotherapy·S GudmundssonW A Craig
Dec 1, 1986·The Journal of Antimicrobial Chemotherapy·F BaqueroM F Vicente
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·T A DrakeM A Sande
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·V Lorian
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·A Dalhoff, G Stübner
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·B S Vogelman, W A Craig
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·P A HunterD A Witting
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·C I BustamanteH C Standiford
Dec 1, 1984·European Journal of Clinical Microbiology·W Craig
Jan 1, 1981·Reviews of Infectious Diseases·R W BundtzenW A Craig
Jan 1, 1981·Reviews of Infectious Diseases·C M Kunin
Oct 1, 1949·Journal of Bacteriology·H Eagle, A D Musselman
Sep 1, 1949·The Journal of Clinical Investigation·H Eagle

❮ Previous
Next ❯

Citations

Nov 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H HanbergerR Maller
May 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H HanbergerM Nilsson
Jun 1, 1996·American Journal of Surgery·J T DiPiroJ M Bohnen
Dec 1, 1993·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·W E OwensC H Ray
May 1, 1993·Antimicrobial Agents and Chemotherapy·S Y TsuiA F Cheng
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·A L WalshN J White
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·F FuentesJ Prieto
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·Q A McKellarD G Jones
Mar 5, 2004·Journal of Veterinary Pharmacology and Therapeutics·K Abo El Sooud
Oct 25, 2017·Molecular Systems Biology·Jaydeep K SrimaniLingchong You
Jun 1, 1994·The Annals of Pharmacotherapy·J C Rotschafer, M J Rybak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.